Page 90 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 3 ฉบับที่ 1
P. 90

88  «“√ “√°“√·æ∑¬å·ºπ‰∑¬·≈–°“√·æ∑¬å∑“߇≈◊Õ°           ªï∑’Ë Û ©∫—∫∑’Ë Ò µÿ≈“§¡ ÚıÙ˜-¡°√“§¡ ÚıÙ¯


            acid, 8-γ,γ -dimethylallylwighteone, 3'-γ,γ -dimethylallylwighteone ¡’ƒ∑∏‘Ϭ—∫¬—Èß cAMP-

            dependent protein kinase catalytic subunit  ¢Õßµ—∫ÀπŸ ‚¥¬§à“§«“¡‡¢â¡¢âπ„π°“√¬—∫¬—Èß∑’Ë 50%
            À√◊Õ IC  ∑’Ë 3.5, 10, 20, 24 ·≈– 33   ‰¡‚§√‚¡≈à“√å  µ“¡≈”¥—∫ ·≈–‡ πÕ«à“  “√‡§¡’∑’Ë¡’ Ÿµ√
                   50
            ‚§√ß √â“߇ªìπ prenyl  (À√◊Õ dimethylallyl) ¥—ß°≈à“«®”‡ªìπµàÕ°“√· ¥ßƒ∑∏‘Ï ´÷ËßÕ“®‡ªìπ‡Àµÿº≈∑’Ë
            √“°‡∂“«—≈¬å‡ª√’¬ß¡’ƒ∑∏‘Ï„π°“√‡∫◊ËÕª≈“À√◊Õ¶à“·¡≈ß°Á‰¥â  (11)

                     ®“°°“√»÷°…“∑“߇§¡’ æ∫«à“  à«π≈”µâπ (‡∂“) ¢Õ߇∂“«—≈¬å‡ª√’¬ß  ª√–°Õ∫¥â«¬ “√‡§¡’
            ª√–‡¿∑ isoflavone ·≈– isoflavone glycoside ®”π«π¡“° ‡™àπ   5,7,4'-trihydroxy-6,3'-
                                                                                         (10)
                                                                     (10)
                             (10)
            diprenylisoflavone ,  5,7,4-trihydroxy-6,8-diprenylisoflavone , lupinisoflavone G ,
                                                 (10)
                                                                                         (10)
                                                                         (10)
            7,8-dihydroxy-4'-methoxyisoflavone , erysenegalensein E , lupinisol A ,
                                          (12)
                          (12)
            eturunagarone , lupalbigenin , 3'-γ,γ -dimethylallylwighteone     (8, 12) , 8-γ,γ -
                                                                    (12)
                                 (12)
            dimethylallylwighteone ,  3,3'-γ,γ -dimethylallylwighteone , derriscandenosides A-
              (13)
                                                   (13)
            E ,  7,8-dihydroxy-4'-methoxyisoflavone , 8-hydroxy-4',7-dimethoxyisoflavone-8-
                                     (13)
            O-β- glucopyranoside , 7-hydroxy-4',8-dimethoxyisoflavone-7-  O-β-
                                                                    (13)
                           (13)
            glucopyranoside , formononetin-7-O-β-glucopyranoside , diadzein-7- O- [α-
                                                             (13)
            rhamnopyranosyl-(1→6)]-β-glucopyranoside , formononetin-7-O- [α-
                                                      (13)
            rhamnopyranosyl-(1→6)]-β-glucopyranoside ,  genistein-7- O- [α-rhamnopyranosyl-
                                                                                     (15)
            (1→6)]-β-glucopyranoside  (8, 13) , derrisisoflavone A-F (10,14) , derriscanosides A-B   ·≈–
                                                        (12)
             “√°≈ÿà¡ coumarins ‡™àπ 4,4'-di-O-methyl scandenin , 4,4'-di-O-methyllonchocarpic acid (12)
                             12)
            ·≈– robustic acid (    à«π‡Àπ◊Õ¥‘π¢Õ߇∂“«—≈¬å‡ª√’¬ß¡’√“¬ß“π°“√æ∫ “√ª√–‡¿∑ steroids ‡™àπ
                                         (16)
            lupeol, taraxerol ·≈– β-sitosterol   ‡ªìπµâπ  à«π√“°¢Õ߇∂“«—≈¬å‡ª√’¬ß æ∫ “√°≈ÿà¡ isoflavone
                                                                               (18)
                                                                 (17)
                                                                                         (17)
            ‰¥â·°à warangalone (À√◊Õ scandenone)  (17, 18) , scandinone , chandalone , osajin ,
                   (19)
                                                                             (18)
                                   (19)
            nallanin   ·≈– chandanin   ·≈–æ∫ “√°≈ÿà¡ coumarin ‰¥â·°à lonchocarpenin , lonchocarpic
            acid (18, 20) ,  scandenin (18-22)
                     °“√∑¥ Õ∫§«“¡‡ªìπæ‘…‡©’¬∫æ≈—π ‚¥¬°“√©’¥ “√ °—¥ 50 % ‡Õ∏“πÕ≈®“° à«π‡Àπ◊Õ
            ¥‘π‡∂“«—≈¬å‡ª√’¬ß‡¢â“™àÕß∑âÕßÀπŸ∂’∫®—°√ æ∫«à“ ¢π“¥∑’ˇªìπæ‘…∑”„ÀâÀπŸµ“¬ 50 % §◊Õ 1 °./°°.  (23)
            ·µà‡¡◊ËÕ„Àâ‚¥¬°“√ªÑÕπ∑“ߪ“° À√◊Õ©’¥„µâº‘«Àπ—ß„π¢π“¥ 10 °./°°. °≈—∫‰¡àæ∫§«“¡‡ªìπæ‘…„¥Ê µàÕ
                     (24)
             —µ«å∑¥≈Õß     ”À√—∫°“√»÷°…“æ‘…‡√◊ÈÕ√—ß (6 ‡¥◊Õπ) π—Èπ ‰¡àæ∫§«“¡º‘¥ª°µ‘„¥Ê∑’ˇ°‘¥®“°§«“¡
            ‡ªìπæ‘…¢Õß “√ °—¥¥â«¬ 50 % ‡Õ∏“πÕ≈„πÀπŸ¢“« ·¡â®–„Àâ “√ °—¥‚¥¬°“√ªÑÕπ ∑“ߪ“°„π¢π“¥
            6, 60, 600 ¡°./°°./«—π À√◊Õ‡∑’¬∫‡∑à“ºß‡∂“«—≈¬å‡ª√’¬ß·Àâß 0.03, 0.3, 3 °./°°./«—π À√◊Õ 1, 10,100
            ‡∑à“¢Õß ¢π“¥∑’Ë„™â„π§πµàÕ«—π (25)
   85   86   87   88   89   90   91   92   93   94   95